North America Smart Pills Market– Industry Trends and Forecast to 2025

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email
US : +1-888-387-2818
UK : +44 208 089 1725

North America Smart Pills Market– Industry Trends and Forecast to 2025

North America
Publish Reports
  • No of pages :
    90
  • No of Figures:
    22
  • No of Tables:
    47
  • Report Type:
    Publish
  • Category:

North America Smart Pills Market, By Product Type (Pharmaceuticals, Housing and Assistive Devices), Service (Institutional Care, Homecare, By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring of Cancer), By Disease Indication (Occult GI Bleeding, Crohn’s Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes, Mental Disorders), By Type (Multiparameter Monitoring, Single Parameter Monitoring), By End User (Hospital, Diagnostic Centers, Others), By Geography (U.S., Canada, Mexico) – Trends and Forecast to 2025

North America Smart Pills Market is estimated to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such as increasing prevalence of gastrointestinal disorders, rising cancer screening awareness programs and technological advancements and R&D investment in smart pills market.

Market Segmentation: North America Smart Pills Market

  • On the basis of application, the North America smart pills market is segmented into capsule endoscopy, drug delivery and patient monitoring of cancer. In 2018, capsule endoscopy is expected to dominate the market with highest market share and growing with the highest CAGR in the forecast period 2018 to 2025.
  • The North America smart pills market on the basis of disease indication is segmented into occult GI bleeding, crohn’s disease, small bowel tumors, celiac disease, inherited polyposis syndromes and mental disorders. In 2018, occult GI bleeding segment is expected to dominate the market.
  • The North America smart pills market on the basis of type is segmented into multiparameter monitoring and single parameter monitoring. In 2018, multiparameter monitoring segment is expected to dominate the market in the forecast period of 2018 to 2025
  • The North America smart pills market on the basis of end user is segmented into hospital, diagnostic centers and others. In 2018, hospital segment is expected to dominate the market with 50.1% market share in the forecast period.

Key Drivers: North America Smart Pills Market

Some of the major factors driving the market for North America smart pills market are increasing prevalence of gastrointestinal disorders and rising cancer screening awareness programs.

Key Points: North America Smart Pills Market

Medtronic is going to dominate the North America smart pills market followed by Otsuka Holdings Company Limited, Olympus Corporation.

The capsule endoscopy segment is expected to dominate the North America smart pills market with highest market share of 53.2%.

Choose Licence Type

Enterprise, Single User

TABLE OF CONTENTS NORTH AMERICA SMART PILLS MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA SMART PILLS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 SECONDARY SOURCES
2.8 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF GASTROINTESTINAL DISORDERS
5.1.2 RISING CANCER SCREENING AWARENESS PROGRAMS
5.1.3 TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENT IN SMART PILLS MARKET
5.1.4 FAVOURABLE REIMBURSEMENT POLICIES FOR CAPSULE ENDOSCOPY
5.1.5 RISING NEED OF MINIMALLY INVASIVE SURGERIES

5.2 RESTRAINTS

5.2.1 HIGH COSTS OF SMART PILLS
5.2.2 ETHICAL CONCERNS RELATED TO SMART PILLS FOR DRUG DELIVERY

5.3 OPPORTUNITIES

5.3.1 NEED FOR RAPID DRUG DEVELOPMENT PROCESS
5.3.2 RISING NEED FOR THE FOCUS AND MOTIVATION IN DAILY LIFE FOR PEOPLE

5.4 CHALLENGES

5.4.1 LACK OF TRAINED STAFF
5.4.2 POSSIBLE HEALTH RISK ASSOCIATED WITH A SMART PILL INSERTED INTO A BODY

6 NORTH AMERICA SMART PILLS MARKET, BY APPLICATION

6.1 OVERVIEW

6.2 CAPSULE ENDOSCOPY

6.2.1 SMALL BOWEL CAPSULE ENDOSCOPY
6.2.2 COLON CAPSULE ENDOSCOPY

6.3 DRUG DELIVERY

6.4 PATIENT MONITORING OF CANCER

7 NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION

7.1 OVERVIEW
7.2 OCCULT GI BLEEDING
7.3 CROHN’S DISEASE
7.4 SMALL BOWEL TUMORS
7.5 CELIAC DISEASE
7.6 INHERITED POLYPOSIS SYNDROMES
7.7 MENTAL DISORDERS

8 NORTH AMERICA SMART PILLS MARKET, BY TYPE

8.1 OVERVIEW
8.2 MULTIPARAMETER MONITORING
8.3 SINGLE PARAMETER MONITORING

9 NORTH AMERICA SMART PILLS MARKET, BY END USER

9.1 OVERVIEW
9.2 HOSPITAL
9.3 DIAGNOSTIC CENTERS
9.4 OTHERS

10 NORTH AMERICA SMART PILLS MARKET, BY GEOGRAPHY

10.1 NORTH AMERICA

10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO

11 NORTH AMERICA SMART PILLS MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

12 COMPANY PROFILE

12.1 MEDTRONIC

12.1.1 COMPANY OVERVIEW
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS

12.2 OTSUKA HOLDINGS COMPANY LIMITED

12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS

12.3 OLYMPUS CORPORATION

12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS

12.4 CAPSOVISION, INC.

12.4.1 COMPANY OVERVIEW
12.4.2 PRODUCT PORTFOLIO
12.4.3 RECENT DEVELOPMENTS

12.5 CHECK CAP

12.5.1 COMPANY OVERVIEW
12.5.2 GEOGRAPHIC PRESENCE
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENTS

12.6 INTROMEDIC

12.6.1 COMPANY OVERVIEW
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS

12.7 JINSHAN SCIENCE & TECHNOLOGY

12.7.1 COMPANY OVERVIEW
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS

12.8 LUCID GROUP LIMITED

12.8.1 COMPANY OVERVIEW
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS

13 RELATED REPORTS

LIST OF TABLES NORTH AMERICA SMART PILLS MARKET

TABLE 1 DIFFERENT CURRENT PROCEDURAL TERMINOLOGY (CPT) CODES FOR CAPSULE ENDOSCOPY PROCEDURES

TABLE 2 PRICES FOR THE CAPSULE ENDOSCOPY

TABLE 3 NORTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2016-2025, (USD MILLION)

TABLE 4 NORTH AMERICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 5 NORTH AMERICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 6 NORTH AMERICA DRUG DELIVERY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 7 NORTH AMERICA PATIENT MONITORING OF CANCER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 8 NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025, (USD MILLION)

TABLE 9 NORTH AMERICA OCCULT GI BLEEDING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 10 NORTH AMERICA CROHN’S DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 11 NORTH AMERICA SMALL BOWEL TUMORS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 12 NORTH AMERICA CELIAC DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 13 NORTH AMERICA INHERITED POLYPOSIS SYNDROMES IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 14 NORTH AMERICA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 15 NORTH AMERICA MENTAL DISORDERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 16 NORTH AMERICA SMART PILLS MARKET, BY TYPE, 2016-2025, (USD MILLION)

TABLE 17 NORTH AMERICA MULTIPARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 18 NORTH AMERICA SINGLE PARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 19 NORTH AMERICA SMART PILLS MARKET, BY END USER, 2016-2025, (USD MILLION)

TABLE 20 NORTH AMERICA HOSPITAL IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 21 NORTH AMERICA DIAGNOSTIC CENTERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 22 NORTH AMERICA OTHERS END USER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 23 NORTH AMERICA SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)

TABLE 24 NORTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 25 NORTH AMERICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 26 NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 27 NORTH AMERICA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 28 NORTH AMERICA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 29 NORTH AMERICA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 30 U.S. SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 31 U.S. CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 32 U.S. SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 33 U.S. MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 34 U.S. SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 35 U.S. SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 36 CANADA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 37 CANADA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 38 CANADA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 39 CANADA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 40 CANADA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 41 CANADA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 42 MEXICO SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 43 MEXICO CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 44 MEXICO SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 45 MEXICO MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 46 MEXICO SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 47 MEXICO SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

LIST OF FIGURES NORTH AMERICA SMART PILLS MARKET

FIGURE 1 NORTH AMERICA SMART PILLS MARKET : SEGMENTATION

FIGURE 2 NORTH AMERICA SMART PILLS MARKET : DATA TRIANGULATION

FIGURE 3 NORTH AMERICA SMART PILLS MARKET : RESEARCH SNAPSHOT

FIGURE 4 NORTH AMERICA SMART PILLS MARKET BOTTOM UP APPROACH

FIGURE 5 NORTH AMERICA SMART PILLS MARKET TOP DOWN APPROACH

FIGURE 6 NORTH AMERICA SMART PILLS MARKET : INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA SMART PILLS MARKET : SEGMENTATION

FIGURE 8 INCREASING PREVALENCE OF GASTROINTESTINAL DISORDERS AND FAVORABLE REIMBURSEMENT POLICIES FOR CAPSULE ENDOSCOPY ARE EXPECTED TO DRIVE THE MARKET FOR NORTH AMERICA SMART PILLS MARKET IN THE FORECAST PERIOD 2018 TO 2025

FIGURE 9 CAPSULE ENDOSCOPY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA SMART PILLS MARKET IN 2018 & 2025

FIGURE 10 ASIA PACIFIC IS THE MAXIMUM GROWING REGION FOR SMART PILLS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA SMART PILLS MARKET

FIGURE 12 PERCENTAGE OF ADULT POPULATION DIAGNOSED WITH GASTROINTESTINAL CONDITIONS IN DIFFERENT COUNTRIES (2017)

FIGURE 13 NORTH AMERICA SMART PILLS MARKET: BY APPLICATION, 2017

FIGURE 14 NORTH AMERICA SMART PILLS MARKET: BY DISEASE INDICATION, 2017

FIGURE 15 NORTH AMERICA SMART PILLS MARKET: BY TYPE, 2017

FIGURE 16 NORTH AMERICA SMART PILLS MARKET: BY END USER, 2017

FIGURE 17 NORTH AMERICA SMART PILLS MARKET SNAPSHOT (2017)

FIGURE 18 NORTH AMERICA SMART PILLS MARKET: BY COUNTRY (2017)

FIGURE 19 NORTH AMERICA SMART PILLS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 20 NORTH AMERICA SMART PILLS MARKET: BY COUNTRY (2017 & 2025)

FIGURE 21 NORTH AMERICA SMART PILLS MARKET, BY APPLICATION (2018 – 2025)

FIGURE 22 NORTH AMERICA SMART PILLS MARKET: COMPANY SHARE 2017 (%)

Please fill in the below form and our sales representatives will get back to you Shortly

Please fill in the below form and our sales representatives will get back to you Shortly

 

`